Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05963971 · ClinicalTrials.gov registry record · NA

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

A NA study of Obesity and Acute Lymphoblastic Leukemia, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
376
Enrollment target
1
Study location

NCT05963971: Recruiting NA study of Obesity and Acute Lymphoblastic Leukemia, sponsored by Columbia University.

NCT05963971 is a NA study of Obesity and Acute Lymphoblastic Leukemia that is actively recruiting participants, run by Columbia University. The registered enrollment target is 376 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05963971, a NA study of Obesity and Acute Lymphoblastic Leukemia, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
376 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is determine the effectiveness of a six-month virtually-delivered dietary education intervention (PEDALL) on the prevention of overweight and obesity (OW/OB) during maintenance chemotherapy in children and adolescents with acute lymphoblastic leukemia (ALL).

Primary Outcome

Number of participants with overweight or obesity as assessed by body mass index (BMI) for age z-scores \>1 will change from baseline following 6 month virtual diet education intervention. BMI z-score will be evaluated at the end of 6-month intervention in the maintenance phase of ALL therapy. BMI z-scores will be classified by comparing age, sex, height and weight to CDC growth charts. OW is defined as BMI z-score ≥ +1.04 , and OB is defined as BMI z-score ≥ +1.645 . For participants ≥20 years

Interventions

  • OTHER Standard of care
  • BEHAVIORAL PEDALL

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 376 participants
Start Date 2024-03-19
Est. Completion 2027-06-23
Phase NA
Columbia University

958 total trials

What NCT05963971 shows while recruiting

NCT05963971 is an interventional study that assigns participants to a tested intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (54% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.

NCT05963971 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05963971 about?

NCT05963971 is a clinical study titled "A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors". The purpose of this study is determine the effectiveness of a six-month virtually-delivered dietary education intervention (PEDALL) on the prevention of overweight and obesity (OW/OB) during maintenance chemotherapy in children and adolescents with acute lymphoblastic leukemia (ALL).

What is the current status of trial NCT05963971?

This trial is currently recruiting. It is a NA study. The enrollment target is 376 participants. The study started on 2024-03-19. Estimated completion is 2027-06-23.

What conditions does trial NCT05963971 study?

This clinical trial studies the following conditions: Obesity, Acute Lymphoblastic Leukemia.

What interventions are being tested in trial NCT05963971?

The interventions under investigation include: Standard of care (OTHER), PEDALL (BEHAVIORAL).

Who is sponsoring clinical trial NCT05963971?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05963971 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05963971's enrollment target sits among peer trials

376 177th of 1053 higher than 877 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03102125 · 376 participants · Phase 4

    Allograft Dysfunction in Heart Transplant

  • NCT05055297 · 376 participants · NA

    SELUTION4BTK Trial

  • NCT05912647 · 376 participants · NA

    Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

  • NCT06696352 · 376 participants · NA

    Partners4Pain & Wellbeing: A Randomized Trial of Community Supported Complementary and Integrative Health Self-management for Back Pain

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05963971, the US trial registry maintained by the National Library of Medicine. NCT05963971 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.